Anthera Pharmaceuticals, Inc. (ANTH) stock gained today 87.24% on 23.9M shares in volume. We profiled ANTH as a potential bounce candidate right after the company’s report of the mixed results for its Phase 2b PEARL-SC clinical study in patients with systemic lupus erythematosus. Today Anthera Pharmaceuticals came out with the positive clinical data from the […]
Lpath, Inc. (LPTN): Undervalued Investment in Biotech Company
email to subscribers As the conclusion in our research on the Sunshine Heart (SSH) we wrote: Join us on Sunshine Heart’s board before mainstream media blows this stock up. SSH stock accomplished a remarkable run-up in just three trading session. SSH shares were tripled in price and only now, week later and Sunshine Heart’s stock […]
Hovnanian Enterprises (HOV) and GSO Capital Partners: $125 Million Arrangement
Hovnanian Enterprises, Inc. (NYSE:HOV) and GSO Capital Partners LP (“GSO”) announced today a land banking arrangement for up to $125 million. GSO, the credit arm of The Blackstone Group (NYSE:BX), will manage funds and acquire a portfolio of land parcels from Hovnanian and option finished lots on a quarterly takedown basis back to Hovnanian. As […]
Misonix, Inc. (MSON): On Watch for the 52W High Breakout
Misonix, Inc. (MSON) announced today its participation in SpineWeek 2012, in Amsterdam, Netherlands. SpineWeek takes place every four years and synchronizes the annual meetings of leading scientific societies, focused on disorders of the spine. SpineWeek had an attendance of over 2,600 individuals, including many recognized leaders in the field from all around the globe. Misonix […]
Ocean Power Technologies (OPTT): Teaming Agreement with Lockheed Martin (LMT)
Ocean Power Technologies, Inc. (OPTT) and Lockheed Martin (LMT) announced today that they have entered into a teaming agreement with the goal of developing a 19 megawatt wave-energy project in Victoria, Australia, one of the largest wave-energy projects announced to date. Lockheed Martin will assist with the design of Ocean Power Technologies’ (OPT) PowerBuoy® technology, […]
New Investment Opportunity Report is Coming to Your Inbox
Congratulations to the PennyStockHaven’s subscribers with the remarkable gains on the Sunshine Heart, Inc. (NASDAQ: SSH). In just 3 trading sessions SSH shares topped $17/share from the initial coverage at $5/share. Be ready for the new investment opportunity research report to be delivered in your inbox at the end of this week: Biotech Company Proprietary […]
Sunshine Heart (NASDAQ: SSH): Undervalued Investment Opportunity
Note: email to subscribers Brief research report on the undervalued investment opportunity: Sunshine Heart, Inc. (NASDAQ: SSH) 1. Company: Sunshine Heart focuses on an innovative cardiac assist therapy to treat heart patients who represent a large and under-served market segment. Company’s lead product, C-Pulse® Heart Assist System, is an innovative approach to assist the heart’s […]
New Undervalued Investment Opportunity Pick is Coming
Congratulations to the PennyStockHaven’s subscribers with gains of over 300% on the MRI Interventions, Inc. (MRIC). MRIC has been profiled at $1+ and topped $5 in a month time-frame. Be ready for the new investment opportunity pick to be delivered in your inbox this Sunday, July 8th, 2012:
WFR, ATPG, ANTH: Today’s Movers for Tomorrow’s Market
MEMC Electronic Materials, Inc. (WFR) announced today that four solar projects in Europe has been executed by company during the second quarter of 2012. Cash received on the closing of these transactions will be included in the company’s second quarter cash balances. MEMC Electronic Materials, Inc. 501 Pearl Drive (City of O’Fallon) St. Peters, MO […]
Aeterna Zentaris Inc. (AEZS): Put it on Watch
Aeterna Zentaris Inc. (NASDAQ: AEZS) announced on June 28th that its Japanese partner Yakult Honsha (“Yakult”) (Tokyo: 2267) has initiated a Phase 1 trial in multiple myeloma, a form of blood cancer, with perifosine, the Company’s oral Akt/PI3K inhibitor drug. Yakult, who are sponsoring and conducting this trial in Japan, reported that a first patient […]